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Background: To evaluate the predictability of refraction following immediate sequential bilateral cataract surgery
(ISBCS) performed under general anaesthesia.
Methods: This is a retrospective review of all ISBCS performed at Kantonsspital Winterthur, Switzerland, between
April 2000 and September 2013. The case notes of 250 patients were reviewed. Patients having full refraction
reported (110 patients/220 eyes) were included. 210 (95 %) eyes had a straight forward phacoemulsification with
posterior chamber intraocular lens implantation, seven eyes had a planned extracapsular cataract extraction (ECCE);
three eyes had an intracapsular cataract extraction.
Results: Both eyes of 110 patients (64 women, 46 men) with a mean age of 79.0 years, standard deviation (SD) ±11.4
(range 26 to 97 years) were included. Median preoperative best corrected visual acuity (BCVA) was 0.5 LogMAR in the
first eye, the interquartile range (IQR) was [0.4, 1.2]; 0.7 LogMAR in the second eye with IQR [0.4, 1.8]. At one month, the
median BCVA was 0.2 LogMAR, IQR [0.1, 0.3] in the first eye, median BCVA was 0.1 LogMAR and IQR [0.0, 0.5] in the
second eye. There were 3 eyes (3 %) that lost 3 lines or more in BCVA at one month (control vs. pre-operatively). In all
three cases, poor visual acuity had been recorded pre-operatively (>1 LogMAR). Achieved refraction was within ±1.0 D
of the target in 83 % of eyes. There were only 5 % (n = 6) of cases where if delayed sequential bilateral extraction had
been performed could potentially intraocular lens (IOL) choice have been adjusted, in four of these cases, target
refraction was within ±1.0 D in the second eye.
Conclusions: ISBCS performed under general anaesthesia achieves target refraction in 83 % of eyes after consideration
of complications, ocular co-morbidities and systemic restrictions. In the majority of cases where IOL power calculation
could be considered, the achieved refraction of the second surgical eye was within ±1.0 D of intended refraction. This
undermines the utility of IOL power adjustments in the second surgical eye.
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While refractive bilateral surgery is nowadays standard
practice, the widespread implementation of immediate
sequential bilateral cataract surgery (ISBCS) has remained
a subject of controversy [1]. A survey of the members of
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perform ISBCS [2]. There is unfounded fear of intraocular
infection associated with ISBCS [3–5], which continues to
be cited as the primary reason why this procedure has not
been implemented as standard practice. To a lesser extent,
reluctance is due to the occasional significant intraocular
lens (IOL) power calculation errors in the first eye that
can potentially be refined and thereby prevented in the
second eye [6].
On the other hand, there are important considerations
for the patient in terms of cost and for healthcare services
due to the resources required—ISBCS approximatelyis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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Table 1 Pre and post-operative visual outcomes
Preoperatively First eye Second eye
VA (LogMAR) 0.52 (0.39,
1.15)
0.40 (0.15,
0.70)
ACD (mm) 2.97 ± 0.46 2.98 ± 0.47
AL (mm) 23.5 ± 1.6 23.6 ± 1.75
SE (D) −1.29 ± 4.79 −0.93 ± 4.59
Sphere (D) −0.72 ± 4.77 −0.34 ± 4.51
Cylinder (D) −1.30 ± 1.30 −1.27 ± 1.25
Target SE (D) −1.00 ± 1.13 −0.78 ± 1.40
IOL used
Plate Zeiss Asphina CT409MP 33 31
Acritec 22 22
Iris fixated Ophtec Artisan 2 2
One piece Acrysof SN60WF 2 2
Zeiss CT37A 13 14
HOYA 251 21 21
HOYA YA65BB 5 6
Ophtec PC292Y (PMMA) 3 4
Polylens Y11P 6 5
Tecnis PCB00 2 2
Post-operatively First eye Second eye
VA (LogMAR) 0.22 (0.10,
0.35)
0.13 (0.01,
0.52)
SE (D) −1.00 ± 1.13 −0.99 ± 1.40
Sphere (D) −0.36 ± 1.09 −0.34 ± 1.39
Cylinder (D) −1.40 ± 1.11 −1.41 ± 1.34
Difference between
target and achieved (D)
0.60 0.69
SE: spherical equivalence, VA: visual acuity, ACD: anterior chamber depth,
AL: axial length
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ments. In particular, this eases the demand on support in-
frastructure for mobility restricted patients [7, 8]. With an
aging population these considerations will be of increased
importance particularly in an era where healthcare is
obliged to focus on cost efficiency. Due to the rapid visual
rehabilitation and obvious practicalities for elderly pa-
tients, some surgeons will perform it on request in the
absence of contraindications [9]. Therefore ISBCS is grow-
ing in popularity worldwide; some regions such as the
Canary Islands have adopted ISBCS as a standard proced-
ure, now 80 % of all cataract surgeries are performed in
this way [10].
The very low risk of bilateral complications following
ISBCS has been well documented, and will in time erode
resistance to the widespread adoption of ISBCS in this
respect. This article focuses on the secondary perceived
impediment i.e., the possible adjustment of IOL power
in the second surgical eye. Therefore, the aim of this
study was to calculate the percentage of eyes where ad-
justments might have proved beneficial in terms of the
visual outcome, refractive error and difference from tar-
get refraction for the first and second surgical eye.
Methods
The retrospective study followed the tenets of the Dec-
laration of Helsinki and was reviewed by the internal
ethics committee of Kantonsspital of Winterthur, the
Canton of Zurich, Switzerland.
Patients
Patient charts of all consecutive ISBCS performed at the
Kantonsspital of Winterthur, Switzerland, performed be-
tween April 2000 and September 2013 were reviewed.
There were 250 patients in total, only those with refrac-
tion available pre- and post-operatively were included in
this study (n = 110). In general, indication for ISBCS was
defined as the need for bilateral cataract surgery (re-
duced visual acuity with evidence of lens opacity as ob-
served at the slit lamp) and where surgery under local
anaesthesia was not feasible due to general health
restrictions.
Calculating IOL power
Biometry was performed with the IOL Master (Carl-
Zeiss AG, Oberkochen, Germany). However, in cases of
high lens opacity, patients had axial length measured
with an A-scan ultrasound (Ocuscan, Alcon, Hünenberg,
Switzerland). In five cases, where patients were unable
to cooperate, the biometry measurements were com-
pleted under general anaesthesia (e.g. Trisomy 21, Par-
kinson’s disease). Where biometry was completed
successfully with the IOL master, the Haigis formula wasused to calculate IOL power, elsewhere, the SRK II/SRK
T formula was used.
Surgical procedure
A total of 210 (95 %) eyes of 109 patients had a straight
forward bimanual phacoemulsification with posterior
chamber intraocular lens implantation. A sclero-corneal
tunnel was created in all but one patient where a clear
cornea incision was made in both eyes. Seven (3 %) eyes
of six patients had a planned extracapsular cataract ex-
traction (ECCE), three (1 %) eyes of three patients had
an intracapsular cataract extraction (ICCE) combined
with an anterior vitrectomy and prepupillary implant-
ation of an Artisan iris-claw lens (Ophtec B.V., Gro-
ningen, Netherlands). Details on IOL implants used are
provided in Table 1. All surgical interventions were per-
formed under general anaesthesia. Mean duration of sur-
gery was 52.7 min, standard deviation (SD) ±15.4 (range
33-119). The surgeries of the first and second eyes were
Table 2 Baseline characteristics and ocular co-morbidities
Baseline Mean SD
Age (years) 79.0 years ±11.4 years
- Distance vision target (0 D, -1 D) 88 (80 %)
- Near vision target (less than -2 D) 22 (10 %)
First operated eye R/L 50/60
Ocular comorbidities Patients Eyes
None 24 48
PEX (Glaucoma) 33 (9) 59 (16)
Primary open angle glaucoma 7 11
Angle closure glaucoma 1 1
Dry AMD 30 52
Choroidal neovascularisation 1 1
Diabetic retinopathy 7 14
Epiretinal membrane 2 3
Retinal vein occlusion 6 6
Vitreous haemorrhage 1 1
Previous retinal detachment 1 1
Hemianopsie 2 4
Amblyopia 10 10
Monocular vision 8 8
Corneal scar due to herpes 1 1
Asymptomatic cornea guttata 5 10
Blepharitis 25 50
Chronic anterior uveitis 1 1
Enophthalmia 2 4
AMD: age related macular degeneration, PEX: pseudo exfoliation
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mary, the methods used comply with the general princi-
ples of ISBCS [11, 12]: Two different instrument sets
were used for surgery and the irrigation fluid was chan-
ged. In general, different LOT-Numbers were not used
for the left and right eye. Intracameral cefuroxime
0.5 ml (1 mg/0.1 mL) for prophylaxis of endophthalmitis
was injected at the end of the surgery. Before surgery of
the second eye, the surgeon and nurse undergo sterile
routines after independent preparation of the second
eye’s operative field. Patients with known α-blocker
medication (e.g. Tamsulosin®, Pradif®) were treated with
topical Atropine 1 % sid for 5 days before surgery. Bleph-
aritis was treated preoperatively with Tobradex® eyedrops
(tobramycin 1 mg/dexamethasone 3 mg) qid for 5 days. If
an intraoperative complication occurred in the first surgi-
cal eye, the second surgery was postponed.
Postoperative regimen
The postoperative regimen included Tobradex® (tobra-
mycin 1 mg/dexamethasone 3 mg) eye drops qid. The
eye drops were tapered over four weeks. Postoperative
controls were one day, one week and one month post-
operatively. This is a retrospective review of patient
case notes. Patients operated under general anaesthesia
normally have the day one follow-up visit performed at
the hospital. In Switzerland, the primary eye care pro-
viders are ophthalmologists rather than optometrists,
therefore, week 1 and month 1 follow-up visits were
more often performed by the referring ophthalmologist.
In this way, only the more complicated cases and those
in close proximity to the hospital continued post-
operative follow-up at the hospital. All follow-up visits
were performed by ophthalmologists. Details on post-
operative complications but not refractive outcomes
were available for all patients.
Results
Patients’ characteristics
In this retrospective study, 250 patient files were
reviewed, of which 110 patients (64 women, 46 men)
with a mean age of 79.0 years, SD ± 11.4 (range 26 years
to 97 years) had suitable data available and were in-
cluded. In all but two patients, surgeries were per-
formed under inpatient conditions. To date, in this
centre, ISBCS is non-standard, reserved only for those
cases where it was not possible to perform straightfor-
ward cataract surgery under topical anaesthesia, due to
the general health condition of the patient (e.g. reduced
mobility, nervous system disorders).
Ocular co-morbidities
Twenty-four patients (22 %) had no ocular co-morbidities,
which could influence surgery/post-operative refraction.Fifty eyes of 33 patients, 30 % of the patient population
had a pseudo-exfoliation syndrome of which 16 eyes of
nine patients had developed pseudo-exfoliation (PEX)
glaucoma. Twelve eyes of eight patients had another type
of glaucoma. There are 63 eyes with two or more ocular
co-morbidities. The additional information is given in
Table 2.
Systemic co-morbidities
One patient had no systemic co-morbidity, 109 patients
had at least one systemic comorbidity, but on average pa-
tients had 3.4 co-morbidities (1–7). Twenty-five (23 %) pa-
tients were receiving oral anticoagulation, 53 patients
(48 %) had heart problems (arrhythmia, heart failure, or
cardiovascular disease), 66 patients (60 %) had high blood
pressure. Thirty-six (33 %) patients had diabetes mellitus.
Twenty-seven (25 %) patients had reduced renal function.
Nineteen (17 %) patients had reduced respiratory function.
Forty (36 %) patients had reduced mobility (e.g. paraple-
gia), 21 patients were morbidly obese (body mass index
(BMI) > 30). Twenty patients (18 %) had suffered cerebral
vascular insult. Fifty-five patients had a history of
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history of cancer.
Visual acuity
Visual acuities were reported according to the recom-
mended guidelines [13]. Median preoperative best cor-
rected visual acuity (BCVA) was 0.5 LogMAR in the first
eye, the interquartile range (IQR) was [0.4, 1.2] Log-
MAR; median BCVA was 0.7 LogMAR with IQR [0.4,
1.8] for the second eye. At week one, the control group’s
median BCVA was 0.4 LogMAR, IQR [0.2, 0.5] Log-
MAR; in the second eye, the median BCVA was 0.2 Log-
MAR, IQR [0.1, 0.5] LogMAR. At month one, the
median BCVA was 0.2 LogMAR, IQR [0.1, 0.3] in the
first eye, median BCVA was 0.1 LogMAR IQR [0.0, 0.5].
There were 3 eyes (3 %) that had lost 3 lines or more in
BCVA at one month (control vs. pre-operatively). In all
three cases, poor visual acuity had been recorded pre-
operatively (>1 logMAR). The gain and loss of Snellen
lines at one month is shown in Fig. 1. Notably, there
were a larger proportion of second surgical eyes that did
not gain any Snellen lines post-operatively, this is be-
cause the eye with the better visual potential was oper-
ated first.
There was no difference observed in myopic eyes
(spherical equivalent (SE) < −4.00 D) from the rest of
the group (SE > −4.00D) in terms of pre-operative visualFig. 1 Histogram showing the distribution of the change in BCVA recordedacuity, divergence from SE or post-operative visual
acuity.
Formulas used
Eighty-four patients had both eyes measured with optical
biometry and the Haigis formula was used to calculate the
target SE, this included 88/110 first eyes and 94/110 sec-
ond eyes measured with optical biometry successfully
measured using optical biometry. In the remaining eyes,
ultrasound was used with either the SRKII formula (n =
20, 13 first eyes/7 second eyes) or SRKT formula (n = 18, 9
first eyes/9 second eyes) to calculate the target SE. There
was a significant difference in the pre-operative LogMAR
BCVA of eyes measured with biometry and ultrasound
(0.5 logMAR vs. 1.7 logMAR) and the average difference
between target SE and achieved (0.42 D vs 0.73 D).
Predictability
In our group, the postoperative refraction was within
±0.5 D of the target in 60 % (n = 41) of first surgical eyes
and 51 % (n = 54) for the second eye. The postoperative
refraction was within ±1.0 D in 81 % (n = 89) for the first
eye and 85 % (n = 94) for the second eye. The postopera-
tive refraction was within ±2.0 D in 95 % (n = 105) for the
first eye and 95 % (n = 104) for the second eye (Fig. 2a).
Examining the subgroup of patients with both eyes that
had pre-operative optical biometry and simple lens IOLone month after immediate sequential bilateral cataract surgery
a b
Fig. 2 Scatter plot of the achieved correction versus the intended correction one month post immediate sequential bilateral cataract surgery i.e.,
predictability of refraction post-operatively in (a) the full group n = 110 and in (b) the subgroup with optical biometry available pre-operatively
and simple lens exchange surgery (n = 78)
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within ±0.5 D of the target in 63 % (n = 49 patients) of first
surgical eyes and 54 % (n = 42) for the second eye. The
postoperative refraction was within ±1.0 D in 86 % (n = 67)
for the first eye and 91 % (n = 71) for the second eye, and it
was within ±2.0 D in 99 % (n = 77) for the first eye and
97 % (n = 76) for the second eye (Fig. 2b).
Twenty patients had post-operative refraction greater
than 1.0 D from target SE in their first operated eye. Two
of these eyes had intraoperative complications; in three
eyes, biometry could only be achieved under general anaes-
thesia; one eye developed choroidal neovascularisation
postoperatively. Pre-operatively, one eye had choroidal neo-
vascularisation, four had age related macular degeneration
(AMD), one had strabismus. Two patients had dementia
thus resulting in unreliable refraction results. Therefore,
there were 6 patients who based on the visual outcome of
the first eye, could have considered adjustments to the IOL
power calculation. In 4 of these 6 patients, the refractive
outcome of the second eyes was within ±1.0 D.
Complications
In 98 patients, there were no intraoperative or postoper-
ative complications observed in either eye. In the
remaining 12 patients, one or more complications were
observed unilaterally, there were no cases of bilateral
complications.
Intraoperative
In one eye, an accidental sulcus implantation led to a
rhexis fixated optic. An intraoperative conversion to ICCE
because of total zonula dialysis was performed in three
eyes (1 %). One IOL implant broke during insertion, andconsequently was replaced intraoperatively. In 18 eyes
of ten patients (9 %), an intraoperative floppy-iris syn-
drome (IFIS) was noted, and in one of these eyes, an iris
prolapse occurred intraoperatively requiring a sectorial
iridectomy.
Postoperative
Postoperative hypertony (IOP > 30 mmHg) was ob-
served in 3 eyes (1 %), ICCE has been performed in two
of these eyes. One eye after ECCE had a postoperative
wound dehiscence with iris incarceration (due to eye
rubbing). One eye (1 %) had a corneal decompensation
(preoperatively Fuchs dystrophy had not been observed
but known PEX glaucoma patient). Following uncom-
plicated phacoemulsification, postoperative conversion
from a dry AMD to a wet AMD was observed in one
eye. One eye had reactivation of herpes keratitis. One
eye suffered from a prolonged anterior chamber in-
flammation (toxic anterior segment syndrome (TASS)
suspect).
Discussion
In most countries, ISBCS is done as the exception rather
than the rule, ophthalmic surgeons state that the fear of
bilateral sight-threatening complications is the limiting
factor, in reality there is a very low risk of bilateral com-
plications [14]. The second and lesser reservation of sur-
geons when performing ISBCS is the loss of the ability
to adjust their IOL calculation for the second eye follow-
ing the visual outcome of first eye. This study demon-
strated the relatively small deviation from target
spherical equivalence in the majority of cases of ISBCS,
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age of cases where IOL calculation could be practically
employed. These results combined with the good final
visual acuity of patients who underwent ISBCS, adds fur-
ther evidence to support a more general acceptance of
ISBCS clinically.
Deviation from target spherical equivalence and post-
operative BCVA outcomes reported here agree well with
earlier retrospective studies [15, 16]. Johansson et al. re-
ported similar predictability: within 1.0 D was achieved
in 71 % of eyes in comparison to the 83 % reported here,
any difference may be due to inconsistencies between
IOL calculation methodologies (optical vs ultrasound)
[16]. Our results were also in line with the results re-
ported from prospective large studies [17, 18], however,
it is worth noting that unlike these prospective studies,
the group reported here had no eligibility criteria. The
results of this article are more representative of the gen-
eral cataract population, with multiple ocular and sys-
temic co-morbidities. In a subgroup of these patients,
where optical biometry was available bilaterally pre-
operatively and where simple crystalline lens-IOL ex-
change was performed, we observed that predictability
increased, surpassing results reported in the other stud-
ies [15].
Olsen et al. suggested a correction of the IOL calcula-
tion of left eye based on the outcomes of the right eye
that may be beneficial. This correction could theoretic-
ally increase the predictability in the second eye (in-
creasing the number of eyes within ±1.0 D) [19]. In our
study group, only 20 patients had a refraction that was
greater than 1.0 D from target SE in their first operated
eye. Examining these patients in detail, we observed that
many patients had additional considerations that would
have inhibited the adjustment of IOL power calculations.
Finally, there were only 6 patients who based on the vis-
ual outcome of the first eye, could have considered ad-
justment to the IOL power calculation. In four of these
six patients, the second eye achieved a refraction that
was within ±1.0 D of the target (with no adjustment
based on achieved refraction of the first eye), therefore
there were two eyes that could have potentially benefit-
ted from such an adjustment, and four that potentially
could have resulted in a worse result due to any such ad-
justment. This suggests that IOL calculation adjustment
based on the surgical outcome of the first eye is not ad-
visable as a rule.
As a retrospective study, the available data is not dir-
ectly comparable to those reported in prospective stud-
ies. For example, the preoperative measurements, the
surgical techniques/surgeon, and the formulas chosen to
calculate the implanted IOL are not uniform; these in-
consistencies will inevitably influence the postoperative
refraction. Moreover, there was no pre-screening ofpatients for inclusion or exclusion criteria, therefore the
patients included here are likely more complex. On the
other hand, a group of senile patients with a multitude
of ocular and general comorbidities is more typical of
general clinical case mix. Lastly, since the refraction was
measured in the clinic, it can be assumed that a propor-
tion of visual acuity measures were sub-optimal. These
factors will impact the reproducibility of our results.
There is a potential bias in the patient selection, as
only 110 patients had pre- and post-operative refraction
available from the full consecutive series of 250 ISBCS
surgeries. Unlike other countries, the operating policy in
Switzerland is to return the patient immediately to the
referring ophthalmologist, with only the more compli-
cated cases and those in close proximity to the hospital
returning to the tertiary centre for post-operative follow-
up. This could potentially have influenced our results
negatively, for example here we observed three conver-
sions to ICCE intraoperatively, however in all the 250
patients notes reviewed, there were no additional cases
of conversion to ICCE.
The formulas used here were the Haigis, SRKT and
SRKII. It is likely that the universal choice (where avail-
able) of the Haigis formula for IOL power calculation,
was suboptimal for longer or shorter eyes. In this study,
there was significant difference in the improvement from
pre- to post-operative BCVA, and it achieved refraction
between the eyes calculated with Haigis and SRK formu-
lae. However, this was likely due to the more compli-
cated cases estimated with the ultrasound rather than
any unsuitability of formula choice. There was no signifi-
cant difference in the divergence from target SE with
myopia, indicating that this was not a highly significant
contributing factor.
Conclusion
This retrospective study demonstrates that ISBCS is a
safe surgical option in terms of refraction. The good pre-
dictability of SE observed here, indicates that only in a
small proportion of eyes could IOL calculation be bene-
ficial between surgery of the first and second eye. This
suggests that there is little merit to delaying the second
surgery with this aim.
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